Document Detail


Assessment of pharmacotherapy for negative symptoms of schizophrenia.
MedLine Citation:
PMID:  20821286     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Negative symptoms in schizophrenia include diminished ability to communicate, motivate, and socialize as potentially debilitating aspects of the illness that are associated with long-term impairment. Despite such burden, the domain has been underrepresented in drug development and treatment research. In this article, we review research regarding pharmacotherapy for negative symptoms, with a focus on studies published during the past 2 years. Clearly positive studies were limited to N-methyl-D-aspartate agonists, while antipsychotics and antidepressants did not show substantial benefit, and cognitive enhancers have yielded mixed results. Proof-of-concept studies of other agents such as minocycline and omega fatty acids yielded promising, albeit preliminary findings that warrant replication. Study outcomes and designs are discussed along with implications for future research.
Authors:
Elizabeth Hanson; Kristin Healey; Daniel Wolf; Christian Kohler
Related Documents :
14993436 - Recent advances in the neurobiology of schizophrenia.
16319376 - Ethical issues in schizophrenia research: a commentary on some current concerns.
2287926 - Is the familial/sporadic subdivision a method of genetics?
23096776 - Midstream modulation in biotechnology industry: redefining what is 'part of the job' of...
17845556 - Mental health nursing research: the contemporary context.
9693346 - Scientific journals and their authors' financial interests: a pilot study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current psychiatry reports     Volume:  12     ISSN:  1535-1645     ISO Abbreviation:  Curr Psychiatry Rep     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888960     Medline TA:  Curr Psychiatry Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  563-71     Citation Subset:  IM    
Affiliation:
Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 19104, USA. elizabgh@upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Getting (the most) out of the research business: interventions for youth with T1DM.
Next Document:  Different mechanisms underlie post-menarchial increase in depression and weight.